Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. ETF
  3. APLS
APLS logo

APLS

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewTechnicalNews
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

APLS News

Investor Rights Law Firm Investigates Multiple Companies

1d agoPRnewswire

Investor Rights Law Firm Investigates Multiple Companies

Apr 14 2026PRnewswire

Biogen Shares Rise After Upgrade and Acquisition Announcement

Apr 14 2026seekingalpha

Investor Rights Law Firm Investigates Multiple Companies

Apr 10 2026PRnewswire

Investor Rights Law Firm Investigates Multiple Companies for Potential Violations

Apr 07 2026PRnewswire

Monteverde Law Firm Investigates Multiple Acquisition Cases

Apr 07 2026Globenewswire

Ademi LLP Investigates Apellis for Potential Fiduciary Breaches in Biogen Deal

Apr 07 2026Globenewswire

Biogen Plans $34 Million Charge Impacting Q1 Earnings

Apr 07 2026Fool

Biogen Plans to Book $34 Million Charge in Q1

Apr 07 2026NASDAQ.COM

Investor Rights Law Firm Investigates Multiple Companies

Apr 02 2026Globenewswire

Biogen's $5.6 Billion Acquisition of Apellis Pharmaceuticals Fails to Boost Stock Price

Apr 01 2026Fool

Biogen to Acquire Apellis Pharmaceuticals for $5.6 Billion

Apr 01 2026NASDAQ.COM

Investor Rights Law Firm Investigates Multiple Companies for Potential Violations

Mar 31 2026Globenewswire

US Stocks Surge on Hopes for End to Iran War

Mar 31 2026NASDAQ.COM

Health Care Stocks Rise 2% Boosting Market

Mar 31 2026Yahoo Finance

Amentum and Eagle Options Trading Activity Surges

Mar 31 2026NASDAQ.COM